AMG 172 First in Human Study in Patients With Kidney Cancer

Share this content:
AMG 172 First in Human Study in Patients With Kidney Cancer

Sponsors and Collaborators
Amgen

Contact
Amgen Call Center    
886-572-6436

Principal Investigator
Amgen

ClinicalTrials.gov Identifier
NCT01497821

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters